Description

Urinary Trypsin Inhibitor Fragment is a fragment derived from urinary trypsin inhibitor by proteolysis. Urinary Trypsin Inhibitor Fragment can inhibit tumor cell invasion by limited proteolysis[1].–Applications-Cancer-Kinase/protease-Formula-C40H66N14O9S-Citation–References-[1]Kobayashi H, et, al. Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion. Clin Exp Metastasis. 1994 Mar;12(2):117-28. -CASNumber-164859-77-2-MolecularWeight-919.11-Compound Purity–SMILES-CC[C@H](C)[C@@H](C(O)=O)NC([C@H](CC1=CC=CC=C1)NC([C@H](C)NC([C@H](CCCNC(N)=N)NC([C@H](CS)NC([C@H]2N(CCC2)C(CNC([C@@H](N)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O-Research_Area-Cancer-Solubility-10 mM in DMSO-Target-Ser/Thr Protease-Isoform–Pathway-Metabolic Enzyme/Protease-MCE Product type-Biochemical Assay Reagents